Enliven Therapeutics Inc
(ELVN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 03-2003 | 12-2002 | 09-2002 | |
| Gross Profit | N/A | N/A | 1,710 | 980 | 6,710 |
| Operating Expenses | 5,557 | 4,194 | 1,250 | 1,280 | 1,530 |
| Operating Income | -5,557 | -4,194 | -1,250 | -1,280 | -1,530 |
| Other Income | 160 | 0 | 0 | 0 | 0 |
| Pre-tax Income | -5,397 | -4,194 | -1,250 | -1,280 | -1,530 |
| Net Income Continuous | -5,397 | -4,194 | -1,250 | -1,280 | -1,530 |
| Net Income | $-5,397 | $-4,194 | $-1,250 | $-1,280 | $-1,530 |
| EPS Basic Total Ops | -30.72 | -23.88 | N/A | N/A | N/A |
| EPS Basic Continuous Ops | -30.73 | -23.88 | N/A | N/A | N/A |
| EPS Diluted Total Ops | -30.72 | -23.88 | N/A | N/A | N/A |
| EPS Diluted Continuous Ops | -30.73 | -23.88 | N/A | N/A | N/A |
| EBITDA(a) | $-5,557 | $-4,194 | $-720 | $-770 | $-770 |